Raaj Medisafe India Limited
BSE: RAAJMEDI
Prev Close
91.74
Open Price
87.25
Volume
400
Today Low / High
87.18 / 87.25
52 WK Low / High
63.56 / 102.35
Range
83 - 92
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 87.18, reflecting a change of -4.56 (-4.97057%). The expected target range on the BSE is 83 - 92. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Raaj Medisafe India Limited Graph
Raaj Medisafe India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Raaj Medisafe India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 87.18, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 87.18 | 88.05 | 79.25 - 96.86 |
| 88.92 | 71.14 - 106.71 | ||
| 89.80 | 62.86 - 116.73 | ||
| Bearish Scenario | 87.18 | 86.31 | 77.68 - 94.94 |
| 85.44 | 68.35 - 102.52 | ||
| 84.56 | 59.20 - 109.93 |
Overview of Raaj Medisafe India Limited
ISIN
INE548H01015
Industry
Medical - Specialties
Vol.Avg
2,183
Market Cap
1,212,123,924
Last Dividend
0
Official Website
IPO Date
2011-11-18
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 62.42 Cr | 43.78 Cr | 18.64 Cr | 0.2986 | 0.00 Cr | 0.00 Cr | 7.18 Cr | 6.13 Cr | 4.55 | 8.83 Cr | 0.0982 |
| 2024-03-31 | 43.25 Cr | 31.63 Cr | 11.62 Cr | 0.2686 | 0.00 Cr | 0.51 Cr | 5.78 Cr | 3.33 Cr | 3.05 | 6.58 Cr | 0.0770 |
| 2023-03-31 | 38.62 Cr | 28.98 Cr | 9.64 Cr | 0.2497 | 0.00 Cr | 0.48 Cr | 4.87 Cr | 3.33 Cr | 3.06 | 5.61 Cr | 0.0862 |
| 2022-03-31 | 34.69 Cr | 25.28 Cr | 9.42 Cr | 0.2714 | 0.00 Cr | 0.96 Cr | 4.37 Cr | 3.01 Cr | 2.82 | 5.11 Cr | 0.0868 |
| 2021-03-31 | 31.81 Cr | 24.00 Cr | 7.80 Cr | 0.2453 | 0.00 Cr | 0.32 Cr | 3.38 Cr | 2.30 Cr | 2.07 | 4.06 Cr | 0.0723 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.06 Cr | 69.22 Cr | 42.30 Cr | 26.9154 Cr | 34.57 Cr | 34.52 Cr | 8.14 Cr | 31.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 27.8675 Cr |
| 2024-03-31 | 0.03 Cr | 41.51 Cr | 30.67 Cr | 10.8367 Cr | 25.87 Cr | 25.84 Cr | 8.46 Cr | 21.02 Cr | 0.00 Cr | 0.00 Cr | 0.07 Cr | 16.1088 Cr |
| 2023-03-31 | 0.01 Cr | 25.77 Cr | 18.28 Cr | 7.4908 Cr | 15.61 Cr | 15.60 Cr | 6.61 Cr | 10.26 Cr | 0.00 Cr | 0.00 Cr | 0.07 Cr | 11.3207 Cr |
| 2022-03-31 | 0.02 Cr | 19.62 Cr | 15.47 Cr | 4.1492 Cr | 13.01 Cr | 12.99 Cr | 3.11 Cr | 9.30 Cr | 0.00 Cr | 0.00 Cr | 0.11 Cr | 9.5061 Cr |
| 2021-03-31 | 0.01 Cr | 16.61 Cr | 15.54 Cr | 1.0720 Cr | 13.13 Cr | 13.11 Cr | 1.52 Cr | 8.86 Cr | 0.00 Cr | 0.00 Cr | 0.07 Cr | 6.5266 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.0868 Cr | -16.4170 Cr | 16.5233 Cr | -14.7964 Cr | 0.0195 Cr | 0.0649 Cr | -14.7096 Cr | 5.1920 Cr | 8.6414 Cr | 0.0000 Cr | 0.3216 Cr |
| 2024-03-31 | 4.2749 Cr | -13.0006 Cr | 8.7434 Cr | -7.3641 Cr | 0.0177 Cr | 0.0442 Cr | -11.6390 Cr | 4.3057 Cr | 10.3084 Cr | 0.0000 Cr | -1.8528 Cr |
| 2023-03-31 | 0.1740 Cr | -1.6652 Cr | 1.4854 Cr | -1.5520 Cr | -0.0058 Cr | 0.0265 Cr | -1.7260 Cr | 3.7826 Cr | 1.1965 Cr | 0.0000 Cr | -3.5029 Cr |
| 2022-03-31 | 2.4452 Cr | -0.9614 Cr | -1.4664 Cr | 1.2348 Cr | 0.0174 Cr | 0.0323 Cr | -1.2104 Cr | 3.7274 Cr | -3.0083 Cr | 0.0000 Cr | -1.5864 Cr |
| 2021-03-31 | 2.2284 Cr | -2.7800 Cr | 0.5133 Cr | -1.6602 Cr | -0.0383 Cr | 0.0149 Cr | -3.8886 Cr | 2.5802 Cr | 1.2578 Cr | 0.0000 Cr | -0.6512 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 24.40 Cr | 18.50 Cr | 5.90 Cr | 0.2417 | 2.67 Cr | 3.48 Cr | 2.58 | 3.22 Cr | 0.1426 |
| 2024-12-31 | 14.59 Cr | 9.27 Cr | 5.32 Cr | 0.3649 | 1.81 Cr | 1.03 Cr | 0.76 | 2.20 Cr | 0.0703 |
| 2024-09-30 | 12.52 Cr | 8.60 Cr | 3.93 Cr | 0.3136 | 1.19 Cr | 0.65 Cr | 0.49 | 1.67 Cr | 0.0521 |
| 2024-06-30 | 10.91 Cr | 7.42 Cr | 3.49 Cr | 0.3200 | 1.51 Cr | 0.97 Cr | 0.74 | 1.74 Cr | 0.0893 |
| 2024-03-31 | 11.36 Cr | 9.34 Cr | 2.01 Cr | 0.1773 | 2.09 Cr | 0.70 Cr | 0.66 | 2.25 Cr | 0.0615 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.05 Cr | 0.01 Cr | 0.06 Cr | 16.70 Cr | 8.14 Cr | 29.62 Cr | 31.57 Cr | 69.22 Cr | 42.30 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -22.47 Cr |
| 2024-09-30 | 0.15 Cr | 0.01 Cr | 0.16 Cr | 8.58 Cr | 11.90 Cr | 26.35 Cr | 27.65 Cr | 58.02 Cr | 35.55 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | -10.84 Cr |
| 2024-03-31 | 0.03 Cr | 0.01 Cr | 0.05 Cr | 8.12 Cr | 8.46 Cr | 18.72 Cr | 21.02 Cr | 41.51 Cr | 30.67 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Specialties
No stocks found in this industry.
Key Executives
Gender: male
Year Born: 1987
Gender: male
Year Born: 1981
Gender: female
Year Born:
Gender: male
Year Born:
FAQs about Raaj Medisafe India Limited
The CEO is Arpit Bangur.
The current price is ₹91.74.
The range is ₹63.56-102.35.
The market capitalization is ₹121.21 crores.
The P/E ratio is 20.18.
The company operates in the Healthcare sector.
Overview of Raaj Medisafe India Limited (ISIN: INE548H01015) is a leading Medical - Specialties in India. With a market capitalization of ₹121.21 crores and an average daily volume of 2,183 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.